← All stocks

REED'S, INC.

REED Net buying
CIK 0001140215 #5208 in the set updated 22 Sep 2026
Bought (120 mo)
$30.12M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$8.08M
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$8.08M
31 of 31 sales
Net
+$22.03M
+$22.03M against sales at will

By person

24 insiders · 109 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
REED CHRISTOPHER J
CIO
$13.56M (2)
$2.24M (25)
+$11.32M
1,475,990
$1.64M
−35.6%
DENG Shufen
Director
$7.90M (2)
+$7.90M
0
$0.00
−100.0%
Bello John
Director
$3.41M (45)
+$3.41M
8,480,416
$9.41M
+272.8%
Doherty Daniel Joseph III
Director
$2.92M (2)
−$2.92M
6,927,724
$7.69M
+6.0%
Raptor/Harbor Reeds SPV LLC entity
10% owner
$4.00M (1)
$2.92M (2)
+$1.08M
3,808,600
$4.23M
+396.8%
Union Square Park Capital Management, LLC entity
10% owner
$796.81K (2)
$11.80K (2)
+$785.00K
1,220,174
$1.35M
+141.1%
Snyder Norman E. Jr.
CEO
$179.50K (4)
+$179.50K
99,869
$110.85K
COHANE NEAL
Chief Sales Officer
$97.28K (3)
+$97.28K
201,277
$223.42K
+21.8%
Bass James C
Director
$68.39K (5)
+$68.39K
556,881
$618.14K
+128.1%
Miles Daniel V.
CFO
$28.96K (1)
+$28.96K
48,200
$53.50K
+60.7%
Iris Snyder
CFO
$25.00K (1)
+$25.00K
127,429
$141.45K
+48.6%
Imbrogno Louis Jr.
Director
$15.00K (2)
+$15.00K
427,217
$474.21K
+434.0%
Grossman Scott R.
Director
$12.08K (2)
+$12.08K
246,119
$273.19K
+207.6%
JAFFE LEWIS
Director
$10.00K (1)
+$10.00K
399,568
$443.52K
+155.0%
Spisak Thomas J.
CFO
$9.63K (1)
+$9.63K
380,717
$422.60K
+288.3%
Burleson Christopher Scott
CCO
(1)
$0.00
29,369
$32.60K
+389.5%
Era Regenerative Medicine Ltd entity
10% owner
(1)
$0.00
28,214,789
$31.32M
+4.0%
Tinnelly Joann Christine
CFO
(1)
$0.00
38,035
$42.22K
+83.7%
Kallman Rhonda
Director
80,344
$89.18K
Kosler Thomas Wayne
Director
40,172
$44.59K
Freeman Stefan
COO
37,037
$41.11K
CARGILE CHARLES F
Director
19,355
$21.48K
Hubli Richard H.
VP Operations
17,857
$19.82K
Stalowir Val
CEO
0
$0.00

No percentages here. This company's share count has moved by a factor of 5.9 over the window, from 8,187,291 to 48,673,722 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 136
Amendments (4/A) skipped 10
Filings about a different issuer 0
Unreadable filings 0
Joint filings 6
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 31
Transactions with no price 8
Shares from compensation/vesting 57,245,382
Sales filed before the plan box existed 29
History held since 2 Sep 2016